Report Detail

Request for Sample of this report

Pharma & Healthcare Global Orally Disintegrating Tablet Excipient Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4716463
    • |
  • 29 June, 2026
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Orally Disintegrating Tablet Excipient market size was valued at US$ 18920 million in 2025 and is forecast to a readjusted size of US$ 23880 million by 2032 with a CAGR of 3.4% during review period.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.
This report is a detailed and comprehensive analysis for global Orally Disintegrating Tablet Excipient market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Orally Disintegrating Tablet Excipient market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2021-2032
Global Orally Disintegrating Tablet Excipient market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2021-2032
Global Orally Disintegrating Tablet Excipient market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2021-2032
Global Orally Disintegrating Tablet Excipient market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Orally Disintegrating Tablet Excipient
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Orally Disintegrating Tablet Excipient market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Orally Disintegrating Tablet Excipient market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Binders
Glidents
Diluents
Disintegrants
Others
Market segment by Application
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Major players covered
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orally Disintegrating Tablet Excipient product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablet Excipient, with price, sales quantity, revenue, and global market share of Orally Disintegrating Tablet Excipient from 2021 to 2026.
Chapter 3, the Orally Disintegrating Tablet Excipient competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orally Disintegrating Tablet Excipient breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Orally Disintegrating Tablet Excipient market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Orally Disintegrating Tablet Excipient.
Chapter 14 and 15, to describe Orally Disintegrating Tablet Excipient sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Orally Disintegrating Tablet Excipient Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Binders
    • 1.3.3 Glidents
    • 1.3.4 Diluents
    • 1.3.5 Disintegrants
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Orally Disintegrating Tablet Excipient Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Anti-Psychotics Drug
    • 1.4.3 Anti-Epileptics Drug
    • 1.4.4 Others
  • 1.5 Global Orally Disintegrating Tablet Excipient Market Size & Forecast
    • 1.5.1 Global Orally Disintegrating Tablet Excipient Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Orally Disintegrating Tablet Excipient Sales Quantity (2021-2032)
    • 1.5.3 Global Orally Disintegrating Tablet Excipient Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 BASF
    • 2.1.1 BASF Details
    • 2.1.2 BASF Major Business
    • 2.1.3 BASF Orally Disintegrating Tablet Excipient Product and Services
    • 2.1.4 BASF Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 BASF Recent Developments/Updates
  • 2.2 JRS Pharma
    • 2.2.1 JRS Pharma Details
    • 2.2.2 JRS Pharma Major Business
    • 2.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Product and Services
    • 2.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 JRS Pharma Recent Developments/Updates
  • 2.3 Roquette
    • 2.3.1 Roquette Details
    • 2.3.2 Roquette Major Business
    • 2.3.3 Roquette Orally Disintegrating Tablet Excipient Product and Services
    • 2.3.4 Roquette Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Roquette Recent Developments/Updates
  • 2.4 ABF Ingredients
    • 2.4.1 ABF Ingredients Details
    • 2.4.2 ABF Ingredients Major Business
    • 2.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Product and Services
    • 2.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ABF Ingredients Recent Developments/Updates
  • 2.5 DFE Pharma
    • 2.5.1 DFE Pharma Details
    • 2.5.2 DFE Pharma Major Business
    • 2.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Product and Services
    • 2.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 DFE Pharma Recent Developments/Updates
  • 2.6 Evonik
    • 2.6.1 Evonik Details
    • 2.6.2 Evonik Major Business
    • 2.6.3 Evonik Orally Disintegrating Tablet Excipient Product and Services
    • 2.6.4 Evonik Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Evonik Recent Developments/Updates
  • 2.7 Merck KGaA
    • 2.7.1 Merck KGaA Details
    • 2.7.2 Merck KGaA Major Business
    • 2.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Product and Services
    • 2.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Merck KGaA Recent Developments/Updates
  • 2.8 Ashland
    • 2.8.1 Ashland Details
    • 2.8.2 Ashland Major Business
    • 2.8.3 Ashland Orally Disintegrating Tablet Excipient Product and Services
    • 2.8.4 Ashland Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Ashland Recent Developments/Updates
  • 2.9 Meggle Pharma
    • 2.9.1 Meggle Pharma Details
    • 2.9.2 Meggle Pharma Major Business
    • 2.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Product and Services
    • 2.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Meggle Pharma Recent Developments/Updates
  • 2.10 Shin-Etsu
    • 2.10.1 Shin-Etsu Details
    • 2.10.2 Shin-Etsu Major Business
    • 2.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Product and Services
    • 2.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Shin-Etsu Recent Developments/Updates
  • 2.11 Fuji Chemical Industries
    • 2.11.1 Fuji Chemical Industries Details
    • 2.11.2 Fuji Chemical Industries Major Business
    • 2.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product and Services
    • 2.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Fuji Chemical Industries Recent Developments/Updates
  • 2.12 McePharma (Vivesa holding)
    • 2.12.1 McePharma (Vivesa holding) Details
    • 2.12.2 McePharma (Vivesa holding) Major Business
    • 2.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product and Services
    • 2.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 McePharma (Vivesa holding) Recent Developments/Updates
  • 2.13 Cargill Incorporated
    • 2.13.1 Cargill Incorporated Details
    • 2.13.2 Cargill Incorporated Major Business
    • 2.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Product and Services
    • 2.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Cargill Incorporated Recent Developments/Updates
  • 2.14 Daicel Corporation
    • 2.14.1 Daicel Corporation Details
    • 2.14.2 Daicel Corporation Major Business
    • 2.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Product and Services
    • 2.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Daicel Corporation Recent Developments/Updates
  • 2.15 Anhui Sunhere Pharmaceutical
    • 2.15.1 Anhui Sunhere Pharmaceutical Details
    • 2.15.2 Anhui Sunhere Pharmaceutical Major Business
    • 2.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product and Services
    • 2.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Anhui Sunhere Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Orally Disintegrating Tablet Excipient by Manufacturer

  • 3.1 Global Orally Disintegrating Tablet Excipient Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Orally Disintegrating Tablet Excipient Revenue by Manufacturer (2021-2026)
  • 3.3 Global Orally Disintegrating Tablet Excipient Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Orally Disintegrating Tablet Excipient by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Orally Disintegrating Tablet Excipient Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Orally Disintegrating Tablet Excipient Manufacturer Market Share in 2025
  • 3.5 Orally Disintegrating Tablet Excipient Market: Overall Company Footprint Analysis
    • 3.5.1 Orally Disintegrating Tablet Excipient Market: Region Footprint
    • 3.5.2 Orally Disintegrating Tablet Excipient Market: Company Product Type Footprint
    • 3.5.3 Orally Disintegrating Tablet Excipient Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Orally Disintegrating Tablet Excipient Market Size by Region
    • 4.1.1 Global Orally Disintegrating Tablet Excipient Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Orally Disintegrating Tablet Excipient Consumption Value by Region (2021-2032)
    • 4.1.3 Global Orally Disintegrating Tablet Excipient Average Price by Region (2021-2032)
  • 4.2 North America Orally Disintegrating Tablet Excipient Consumption Value (2021-2032)
  • 4.3 Europe Orally Disintegrating Tablet Excipient Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Orally Disintegrating Tablet Excipient Consumption Value (2021-2032)
  • 4.5 South America Orally Disintegrating Tablet Excipient Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Orally Disintegrating Tablet Excipient Sales Quantity by Type (2021-2032)
  • 5.2 Global Orally Disintegrating Tablet Excipient Consumption Value by Type (2021-2032)
  • 5.3 Global Orally Disintegrating Tablet Excipient Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Orally Disintegrating Tablet Excipient Sales Quantity by Application (2021-2032)
  • 6.2 Global Orally Disintegrating Tablet Excipient Consumption Value by Application (2021-2032)
  • 6.3 Global Orally Disintegrating Tablet Excipient Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Orally Disintegrating Tablet Excipient Sales Quantity by Type (2021-2032)
  • 7.2 North America Orally Disintegrating Tablet Excipient Sales Quantity by Application (2021-2032)
  • 7.3 North America Orally Disintegrating Tablet Excipient Market Size by Country
    • 7.3.1 North America Orally Disintegrating Tablet Excipient Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Orally Disintegrating Tablet Excipient Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Orally Disintegrating Tablet Excipient Sales Quantity by Type (2021-2032)
  • 8.2 Europe Orally Disintegrating Tablet Excipient Sales Quantity by Application (2021-2032)
  • 8.3 Europe Orally Disintegrating Tablet Excipient Market Size by Country
    • 8.3.1 Europe Orally Disintegrating Tablet Excipient Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Orally Disintegrating Tablet Excipient Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Orally Disintegrating Tablet Excipient Market Size by Region
    • 9.3.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Orally Disintegrating Tablet Excipient Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Orally Disintegrating Tablet Excipient Sales Quantity by Type (2021-2032)
  • 10.2 South America Orally Disintegrating Tablet Excipient Sales Quantity by Application (2021-2032)
  • 10.3 South America Orally Disintegrating Tablet Excipient Market Size by Country
    • 10.3.1 South America Orally Disintegrating Tablet Excipient Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Orally Disintegrating Tablet Excipient Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Orally Disintegrating Tablet Excipient Market Size by Country
    • 11.3.1 Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Orally Disintegrating Tablet Excipient Market Drivers
  • 12.2 Orally Disintegrating Tablet Excipient Market Restraints
  • 12.3 Orally Disintegrating Tablet Excipient Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Orally Disintegrating Tablet Excipient and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Orally Disintegrating Tablet Excipient
  • 13.3 Orally Disintegrating Tablet Excipient Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Orally Disintegrating Tablet Excipient Typical Distributors
  • 14.3 Orally Disintegrating Tablet Excipient Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Orally Disintegrating Tablet Excipient. Industry analysis & Market Report on Orally Disintegrating Tablet Excipient is a syndicated market report, published as Global Orally Disintegrating Tablet Excipient Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Orally Disintegrating Tablet Excipient market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo